USA IoT in Healthcare Market

The USA IoT in Healthcare Market is estimated at USD 54,200 Mn in 2025. The scope includes connected medical devices and sensors, device-management and clinical software, managed connectivity, integration, cybersecurity, analytics, and recurring monitoring services. It excludes general-purpose enterprise IT, unconnected medical equipment, traditional telecommunication revenue unrelated to healthcare applications, and consumer electronics without a meaningful healthcare function. The estimate was triangulated through supplier revenues, active endpoint economics, healthcare technology expenditure, public reimbursement data, and North American market benchmarks.

The market is forecast to grow at an 18.0% CAGR from 2026 to 2031, reaching USD 146,315 Mn. Expansion will be driven by connected chronic-care programs, hospital-at-home workflows, continuous diagnostics, connected implants, smart-hospital infrastructure, and enterprise cybersecurity. Market value is expected to grow faster than endpoint volume because each installed device will support more software, analytics, connectivity, maintenance, and clinical-service revenue. Forecast execution depends on reimbursement continuity, patient engagement, interoperability, security controls, and evidence that deployments reduce avoidable utilization or improve clinical productivity.

Profit pools will progressively shift from standalone hardware toward integrated device-platform-service offerings. Hardware remains necessary because regulated sensors, monitors, implants, diagnostic instruments, and gateways create the data source and installed base. However, higher-value recurring revenue will increasingly come from device management, clinical analytics, interoperability, cybersecurity, cloud hosting, patient engagement, and monitoring operations. Vendors controlling both the device and longitudinal data workflow can improve account retention and revenue per endpoint, while hardware-only suppliers face greater pricing pressure, component exposure, and distributor dependence.

Cybersecurity is the most material systemic constraint because connected devices combine patient safety, protected health information, network availability, and regulated product responsibilities. Large health-data breaches affected approximately 242.9 million individuals during 2024, with hacking and IT incidents representing 81% of reported large breaches. Buyers are therefore requiring device inventories, segmentation, authentication, encryption, software bills of materials, vulnerability disclosure, patch processes, and incident response. Suppliers unable to demonstrate lifecycle security may face slower procurement, contractual liability, remediation expense, and reduced access to large health-system accounts.

The United States is the largest market among the selected advanced-economy peers, ahead of Japan, Germany, the United Kingdom, and Canada. Its advantage comes from healthcare expenditure of USD 15,474 per person, a large hospital base, significant medical-device production, reimbursed remote monitoring, venture funding, and established digital-health procurement. The United States also has a more fragmented multi-payer and provider environment, which increases integration complexity but creates multiple commercial channels. Canada and the United Kingdom offer strong virtual-care potential, while Germany and Japan provide advanced medical-device and aging-population demand.

Reimbursement-backed remote patient monitoring has the clearest near-term commercial impact because it converts connected-device deployment into recurring provider revenue. Medicare paid USD 536 Mn for RPM in 2024, an increase of 31% from 2023, while nearly 1 million beneficiaries received the services. This supports demand for monitoring devices, cellular connectivity, patient onboarding, clinical dashboards, alert management, and billing support. Chronic disease and population aging expand the eligible cohort, but program economics still depend on patient engagement, staffing productivity, documentation quality, and appropriate utilization.

Winning suppliers need regulated-device expertise, reliable connectivity, interoperability, cybersecurity-by-design, clinical workflow integration, analytics, and measurable economic outcomes. Enterprise buyers increasingly evaluate deployment support, integration time, alert burden, patient adherence, uptime, vulnerability remediation, and total cost of ownership. Vendors also require flexible commercial models spanning capital purchase, device leasing, per-member-per-month subscriptions, platform licensing, and managed services. Scale alone is insufficient because buyers need proof that connected data can be converted into timely clinical action without creating excessive staff workload or new security risk.